A letter signed by four U.S. senators was recently sent to Jim Jones, FDA Deputy Commissioner for Human Foods, about the agency’s plans for reduced funding for state and local food safety programs, which could significantly affect inspections.
Boar’s Head has responded to a letter from 22 members of Congress probing the company about the recent, fatal listeriosis outbreak linked to its products. Representative Rosa DeLauro (D-CT), who signed the letter, called Boar’s Head’s response “not credible” and “a classic corporate dodge.”
In a recent Senate hearing, top U.S. Food and Drug Administration (FDA) officials shared how resource constraints hinder its food chemical safety review work, and provided insight into a pending decision about red dye 3’s authorization for food use.
A letter written to the U.S. Food and Drug Administration (FDA) by 23 members of Congress urges the agency to ban from food use red dye 3, a controversial synthetic colorant that is potentially harmful to human health.
U.S. Senators Edward Markey and Cory Booker recently wrote a letter to the U.S. Food and Drug Administration (FDA) urging the agency to revoke its authorization for phthalates in food contact materials, arguing that the chemicals are proven to be toxic.
Members of Congress have written a letter to the U.S. Department of Agriculture (USDA) asking the agency to answer questions about its inspection actions leading up to the fatal Boar’s Head listeriosis outbreak, and about its authorities and processes for preventing such events.
Recently introduced to U.S. Congress, the Federal and State Food Safety Information Sharing Act aims to grant the U.S. Food and Drug Administration (FDA) the authority to share crucial food safety information with state and local regulatory agencies to improve foodborne illness outbreak response.
In a letter addressed to key U.S. congressional leaders, the Safe Food Coalition (SFC) expressed its opposition to the DIRECT Act, the PRIME Act, and the New Markets Act, which would lift prohibitions on the interstate sale of meat and poultry from state inspected facilities and allow commercial sales from uninspected “custom” slaughter facilities.
The Alliance for a Stronger FDA has published its “ask” for Fiscal Year 2025 funding for the U.S. Food and Drug Administration (FDA), which is $214 million more than the Presidential budget request submitted by FDA for FY 2025.
The U.S. House of Representatives’ Committee on Oversight and Accountability will hold a hearing on April 11, 2024 to question FDA Commissioner Robert M. Califf, M.D. about the agency’s failure to prevent recent food safety crises.
